Cancer Incidence and Mortality for Schoharie County, 2016-2020

Source: New York State Cancer Registry

Site of Cancer Incidence Mortality
Males and Females Males Females Males and Females Males Females
Average Annual Cases Rate per 100,000 Population 95% CI Average Annual Cases Rate per 100,000 Males 95% CI Average Annual Cases Rate per 100,000 Females 95% CI Average Annual Deaths Rate per 100,000 Population 95% CI Average Annual Deaths Rate per 100,000 Males 95% CI Average Annual Deaths Rate per 100,000 Females 95% CI
All Invasive Malignant Tumors 222.6 466.6 437.9-496.8 116.8 489.2 448.5-533.1 105.8 447.4 407.3-490.8 73.0 148.8 133.4-165.7 40.8 171.9 148.4-198.7 32.2 127.2 107.5-150.1
Oral cavity and pharynx 7.4 15.4 10.7-21.9 5.6 24.2 15.8-36.2 1.8 6.9 3.1-14.6 1.2 2.3 0.8-5.8 0.8 3.0 0.8-9.4 0.4 1.5 0.2-7.5
Esophagus 2.6 5.1 2.6-9.4 2.0 8.0 3.7-16.2 0.6 2.3 0.4-8.7 1.4 2.4 0.9-5.7 1.2 4.2 1.5-10.7 0.2 0.6 0.0-6.1
Stomach 2.2 4.7 2.3-9.0 1.4 6.0 2.4-13.5 0.8 3.5 0.9-10.3 1.0 2.0 0.6-5.5 0.8 3.5 0.9-10.2 0.2 0.6 0.0-6.1
Colorectal 15.4 33.3 26.0-42.4 8.0 36.7 25.7-51.3 7.4 29.4 20.4-42.0 5.4 11.6 7.5-17.6 2.6 11.8 6.0-21.6 2.8 11.3 6.0-20.4
Colon excluding rectum 10.4 22.4 16.4-30.2 5.0 23.3 14.6-35.9 5.4 21.1 13.6-32.2 4.8 10.2 6.3-15.9 2.4 10.9 5.3-20.5 2.4 9.3 4.6-17.8
Rectum & rectosigmoid 5.0 10.9 7.0-16.5 3.0 13.4 7.4-23.1 2.0 8.3 3.9-16.6 0.6 1.4 0.3-4.8 0.2 0.9 0.0-6.6 0.4 2.0 0.2-8.4
Liver / intrahepatic bile duct 3.8 7.0 4.2-11.6 3.2 11.6 6.6-20.1 0.6 2.5 0.5-9.0 2.0 3.7 1.8-7.6 1.6 6.1 2.6-13.3 0.4 1.5 0.2-7.3
Pancreas 7.2 14.0 9.7-19.9 2.8 11.9 6.5-21.1 4.4 16.1 10.0-25.7 5.0 10.5 6.6-16.1 2.2 9.9 4.9-18.7 2.8 11.6 6.0-21.1
Larynx 1.0 2.0 0.6-5.5 1.0 4.1 1.3-10.9 0.0 0.0 0.0-5.4 0.4 0.9 0.1-3.9 0.4 1.8 0.2-7.8 0.0 0.0 0.0-5.4
Lung and bronchus 32.0 62.4 52.8-73.6 16.6 66.5 52.5-83.8 15.4 58.6 45.8-74.8 21.6 44.9 36.4-55.0 11.4 49.1 36.7-64.9 10.2 41.0 29.9-55.5
Melanoma of the skin 8.4 19.2 13.4-26.9 4.6 20.2 12.4-31.8 3.8 18.8 10.6-31.0 1.2 3.1 1.1-7.3 1.2 6.5 2.3-15.1 0.0 0.0 0.0-5.4
Female breast             31.0 132.7 110.8-158.0             3.6 14.2 8.2-23.7
Cervix uteri             1.6 10.0 4.0-20.7             0.4 1.8 0.2-8.1
Corpus uterus and NOS             7.8 31.1 21.7-44.1             0.6 2.3 0.5-8.4
Ovary             1.6 7.3 2.8-16.1             1.4 5.1 2.0-12.0
Prostate       28.0 108.1 90.6-128.6             5.0 20.6 13.2-31.4      
Testis       1.0 7.1 2.2-17.0             0.0 0.0 0.0-5.3      
Urinary bladder (incl. in situ) 13.2 26.4 20.2-34.1 10.2 42.1 31.0-56.5 3.0 11.9 6.6-20.9 1.4 2.7 1.1-6.3 1.0 3.9 1.3-10.6 0.4 1.6 0.2-7.5
Kidney and renal pelvis 10.0 19.9 14.6-26.9 6.8 27.5 18.7-39.7 3.2 12.5 7.0-21.7 2.2 4.3 2.2-8.4 1.0 4.1 1.3-11.0 1.2 4.6 1.7-11.5
Brain and other central nervous system 3.4 7.5 4.1-12.9 3.0 12.3 6.5-21.8 0.4 3.1 0.3-11.3 2.6 5.1 2.6-9.4 2.4 9.3 4.6-17.8 0.2 0.9 0.0-6.6
Thyroid 6.4 18.1 12.0-26.4 1.2 6.8 2.1-16.2 5.2 29.7 18.7-44.8 0.2 0.4 0.0-3.3 0.0 0.0 0.0-5.3 0.2 0.9 0.0-6.6
Hodgkin lymphoma 1.2 3.8 1.3-8.6 0.8 4.8 1.3-12.9 0.4 2.7 0.2-10.5 0.0 0.0 0.0-2.7 0.0 0.0 0.0-5.3 0.0 0.0 0.0-5.4
Non-Hodgkin lymphomas 7.6 15.9 11.1-22.6 3.8 16.1 9.6-26.1 3.8 16.3 9.4-26.9 3.6 7.3 4.2-12.2 2.0 7.8 3.7-15.6 1.6 6.7 2.7-14.6
Myeloma 3.0 5.7 3.1-10.3 2.2 7.7 3.8-15.3 0.8 3.8 0.8-11.5 1.0 2.2 0.7-5.7 0.8 3.5 0.9-10.2 0.2 1.1 0.0-7.2
Leukemias 8.0 17.4 12.1-24.5 5.6 25.5 16.3-38.4 2.4 9.3 4.7-17.5 3.2 6.9 3.9-11.7 2.0 9.3 4.4-18.0 1.2 4.8 1.7-12.0

Notes

  • Incidence data are provisional, November 2022.
  • Rates are per 100,000 persons, age-adjusted to the 2000 US standard population, with 95% confidence intervals.
  • Rates based on fewer than 4 cases or deaths per year are unstable and should be used with caution. NOS = Not otherwise specified.